Urolithin A has antiplatelet effects in contrast to its glucuronide, urolithin B, and isourolithin A

Alina Soloviova, Marcel Hrubša, Carlos J. García, Zuzana Lomozová, Francisco A. Tomás-Barberán, Přemysl Mladěnka

Open source

DOI: 10.3389/fcvm.2026.1843932
Published: 2026-09-15
Container: Frontiers in Cardiovascular Medicine
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2026.1843932,
  title = {Urolithin A has antiplatelet effects in contrast to its glucuronide, urolithin B, and isourolithin A},
  author = {Alina Soloviova and Marcel Hrubša and Carlos J. García and Zuzana Lomozová and Francisco A. Tomás-Barberán and Přemysl Mladěnka},
  year = {2026},
  journal = {Frontiers in Cardiovascular Medicine},
  doi = {10.3389/fcvm.2026.1843932},
  url = {https://doi.org/10.3389/fcvm.2026.1843932}
}

RIS

TY  - JOUR
TI  - Urolithin A has antiplatelet effects in contrast to its glucuronide, urolithin B, and isourolithin A
AU  - Alina Soloviova
AU  - Marcel Hrubša
AU  - Carlos J. García
AU  - Zuzana Lomozová
AU  - Francisco A. Tomás-Barberán
AU  - Přemysl Mladěnka
PY  - 2026
JO  - Frontiers in Cardiovascular Medicine
DO  - 10.3389/fcvm.2026.1843932
UR  - https://doi.org/10.3389/fcvm.2026.1843932
ER  -

APA

Soloviova, A., Hrubša, M., García, C. J., Lomozová, Z., Tomás-Barberán, F. A., & Mladěnka, P. (2026). Urolithin A has antiplatelet effects in contrast to its glucuronide, urolithin B, and isourolithin A. Frontiers in Cardiovascular Medicine. https://doi.org/10.3389/fcvm.2026.1843932

Source records

crossref · retrieved 2026-11-03T23:39:12.920Z